Aditum Bio Fund 1, L.P. — Form D/A
Aditum Bio Fund 1, L.P. of OAKLAND, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2020-10-23. The offering totals $133.0M, of which $133.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-10-23
- Form: D/A
- Accession: 0001782206-20-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $133.0M
- Amount sold: $133.0M
- Investors: 26
- Date of first sale: 2019-07-19
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-344544
Issuer
- Name: Aditum Bio Fund 1, L.P.
- CIK: 0001782206
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1111 BROADWAY, SUITE 1300, OAKLAND, CA, 94607
- Phone: (650) 843-5000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| N/A Aditum Bio GP 1, LLC | Director | Oakland, CA |
| Mark Fishman | Director | Oakland, CA |
| Joseph Jimenez | Director | Oakland, CA |
| Paul Sekhri | Director | New York, NY |
| N/A TrialSpark, Inc. | Director | Oakland, CA |
Other filings by this issuer (1)
More